Pyrrosia lingua for Health & Longevity - Quick Reference Sheet

Pyrrosia lingua for Health & Longevity

Created on 07/22/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Pyrrosia lingua (Shi Wei) is a centuries-old Chinese fern brewed as a gentle water-clearing tea for urinary health. Its best-supported use is helping the body flush and resist kidney stones and urinary irritation, backed by animal studies and long tradition. Signals for bone, blood sugar, and broad cell protection are far weaker, and no human studies exist. (Full Review)

Protocol

Dose
5–10 g/day
Dried leaf decocted (simmered); severe cases historically 15–30 g
Timing
Morning & early afternoon
Avoid evening doses to prevent night-time urination
Schedule
2–3 divided doses
Short-lived plant acids favor split dosing over one large dose
Time to effect
Diuretic effect
Within hours
Felt soon after a dose
Stone prevention
Weeks–months
Not directly self-perceived
Bone effects
Weeks–months
Speculative; cannot be self-perceived

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • Advanced chronic kidney disease (eGFR <30 mL/min/1.73 m²)
  • Clinically low blood pressure or active dehydration
  • Weak, "cold" digestion or dryness/"yin deficiency" without damp-heat
Key Interactions
  • Prescription diuretics (thiazides such as hydrochlorothiazide; loop diuretics such as furosemide)
  • Lithium
  • Antidiabetic drugs (metformin, sulfonylureas such as glipizide, insulin)
  • Antibiotics, especially fluoroquinolones (levofloxacin, ciprofloxacin)
  • Over-the-counter agents (NSAIDs such as ibuprofen; OTC diuretics; caffeine)
  • Diuretic or hypoglycemic supplements (dandelion, Java tea, uva ursi, berberine)

Risk & Side Effects

  • Low: Gastrointestinal upset
  • Speculative: Restlessness and dizziness at high doses; electrolyte loss and additive diuretic effects; heavy-metal or contaminant exposure from wild material; unknown safety in pregnancy and breastfeeding

Monitoring

Marker Target Why
Serum potassium 4.0–4.5 mmol/L Detects diuretic-related loss
Serum sodium 137–142 mmol/L Flags over-diuresis / dilution
Estimated glomerular filtration rate (eGFR) >90 mL/min/1.73 m² Confirms kidneys tolerate a diuretic
Blood urea nitrogen (BUN) 10–16 mg/dL Screens for dehydration/kidney stress
24-hour urinary oxalate <25 mg/day Tracks stone-forming risk
24-hour urinary citrate >320 mg/day Higher levels protect against stones
Urine pH 6.0–6.5 Influences crystal formation
High-sensitivity C-reactive protein (hs-CRP) <1.0 mg/L General inflammation tracking

Cadence: Baseline, then a follow-up at 4–8 weeks if used continuously, then every 6–12 months; electrolytes checked sooner if combined with a pharmaceutical diuretic

Qualitative Assessment

  • Urinary comfort — less burning, urgency, or difficulty
  • Urinary frequency and stream — steady, without night-time disruption
  • Absence of flank or lower-abdominal pain suggestive of stones
  • Digestive comfort — no new nausea or loose stools signaling the "cold" effect
  • General energy and hydration status — no light-headedness or excessive thirst